Young Joon Hong

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Tissue Engineered Bio‐Blood‐Vessels Constructed Using a Tissue‐Specific Bioink and 3D Coaxial Cell Printing Technique: A Novel Therapy for Ischemic Disease

Ge Gao, Jun Hee Lee, Jinah Jang et al. · Advanced Functional Materials · 2017 · 332 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome

Jae‐Min Kim, Robert Stewart, Yong‐Seong Lee et al. · JAMA · 2018 · 200 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Intravascular Ultrasound Parameters Associated With Stent Thrombosis After Drug-Eluting Stent Deployment

Teruo Okabe, Gary S. Mintz, Ashesh N. Buch et al. · The American Journal of Cardiology · 2007 · 171 citations

Medicine, Cardiology, Pharmacology +16